FDA inspection
GlaxoSmithKline Vaccines S.r.l.: FDA inspection ending May 29, 2017
FDA inspection 1030020 · Voluntary Action Indicated (VAI) · Siena
Key facts
| Inspection ID | 1030020 |
|---|---|
| Firm | GlaxoSmithKline Vaccines S.r.l. |
| FEI number | 3007780504 |
| Address | Via Fiorentina 1 |
| City | Siena |
| Country | Italy |
| Fiscal year | 2017 |
| Inspection end date | May 29, 2017 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Vaccines and Allergenic Products |
| Product type | Biologics |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data